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 “Believe you can and you’re halfway there”  
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Abstract 
 
Exposure to low levels of EDCs may be of concern. There is a ubiquitous 
presence of EDCs in today's environment and a frequent detection of their presence in 
blood and urine during population surveys. The near omnipresence of the exposures 
combined with the nontrivial potential health effects due to a sensitivity to low levels of 
EDCs will directly influence the health of current and future populations. Bisphenol A is 
a small molecule which is used as a monomer in polymerization reaction to produce 
polycarbonate plastics, epoxy resins and other polymer materials for manufacturing 
plastic utensils and is among the highest-production-volume chemicals in the world. In 
a process commonly referred to as “leaching”, BPA seeps into the contents of various 
food and water packages and into dust particles, providing ample entry ways for BPA 
into physiological systems of animals and humans. Measurements by the CDC revealed 
detectable levels of BPA in the urine samples of 92.6% of more than 2500 participants 
of the cross sectional NHANES study, with the adjusted mean BPA levels being 
reported at 4.5 ng/ml in children, 3.0 ng/ml in adolescents and 2.5 ng/ml in adults. BPA 
exposure is associated with multiple diseases within multiple biological systems, with 
recent studies, especially regarding model-animals suggesting that BPA exposure may 
have a significant role in the development of obesity, insulin resistance, and 
subsequently have relevance in the development of diabetes mellitus.  
In this work we evaluated the role of endocrine disruption in the regulation of 
pancreatic beta cell activity.  For that we analyzed the effect of BPA at the concentration 
of 1 nM on mouse pancreatic Islets of Langerhans, mouse embryonic fibroblast (MEF) 
and hepatocytes, given the specific role that each of this cellular types may have in the 
homeostasis of the organism, through an transcriptomical approach.  
Through the analysis of the microarray data we were able to conclude that at 48 
hours BPA at the concentration of 1 nM was able to deregulate the expression of a small 
group of genes, related to oxidative phosphorylation and mitochondrial dysfunction, 
specifically in β-Islets. Given this information it was decided to access the cellular 
viability and ATP production and the apoptosis at the singular cell level with the same 
treatment conditions, and our data showed that there is reduction of the cellular viability 
and ATP production and the apoptosis signal was visible through IF. Finally after an 
 ix 
 
analysis of the expression of Bax that was significantly up-regulated. A preliminary 
treatment with possible inhibitors of the apoptosis promoted by BPA was prepared and 
the Bax expression was evaluated. Surprisingly there was an inhibition of the expression 
of Bax when the IKK inhibitor BMS-345541 was used, suggesting a possible pathway 
for the promotion of apoptosis by BPA that goes through the NFkB.  
Since BPA showed a role in the promotion of apoptosis in mouse β-Islets. we 
could conclude that our results were consistent with the association between the 
development of Diabetes and the exposition to environmentally relevant doses of BPA 
present in literature. 
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Resumo 
 
A exposição a niveis reduzidos de disruptores endocrinos é uma questão 
relevante. Existe uma ubiquidade destes EDCs no ambiente e a detecção frequente da 
sua presença em exames ao sangue e urina de diversas populações.  A omnipresença das 
exposições combinada com um risco elevado para a saúde devido a uma sensibilidade a 
níveis reduzidos destes EDCs irá afectar a saúde de várias gerações. O Bisfenol A é um 
pequena molécula utilizada em reacções de polimerização para a produção de plásticos 
policarbonatos, resinas e outros polímeros usados no fabrico de utensílios plásticos e 
hoje em dia encontra-se entre os químicos mais produzidos no planeta. Num processo 
denominado “leaching”, o BPA tem a capacidade de se infiltrar no conteúdo dos seus 
recipientes (comida, água) e em partículas de pó, providenciando uma ampla 
possibilidade de entrada em sistemas fisiológicos. Num estudo realizado pelo CDC no 
qual participaram mais de 2500 indivíduos verificou-se que 92.6% dos indivíduos 
possuíam níveis detectáveis de BPA na urina, sendo que os níveis médios ajustados 
variavam com a idade, sendo reportado como 4.5ng/ml em crianças, 3.0ng/ml em 
adolescentes e 2.5ng/mlem adultos. A exposição ao BPA encontra-se associada a 
múltiplas doenças em diversos sistemas biológicos, sendo que, estudos recentes 
atribuem a esta exposição um papel relevante no desenvolvimento de obesidade, 
resistência à insulina e subsequentemente o aparecimento de Diabetes Mellitus. 
Neste trabalho, avaliamos o papel da disrupção endócrina na regulação da 
actividade de células β-pancreáticas. Para esta análise foi realizada uma avaliação do 
efeito do BPA a uma concentração de 1 nM em Islets de Langerhans de murganho, MEF 
e hepatócitos, devido ao papel que cada um destes tipos celulares desempenha ao nível 
homeostasia do organismo, através duma abordagem de avaliação transcriptómica. A 
análise dos microarrays permitiu inferir que após uma exposição de 48 horas a uma 
concentração de 1nM o BPA causou a desregulação de um pequeno grupo de genes 
relacionados com a fosforilação oxidativa e disfunção mitocondrial, especificamente em 
β-Islets. Portanto foi decidido avaliar se existiria um efeito na viabilidade celular, 
produção de ATP e a apoptose ao nível celular singular (através de Imunofluorescência), 
tendo os resultados revelado reduções de viabilidade celular e produção de ATP e a 
presença de sinal apoptótico com as mesmas condições de tratamento. Por fim, após a 
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verificação do aumento da expressão do gene pró-apoptótico Bax foi realizado um pré-
tratamento com possíveis inibidores de vias apoptóticas com intuito de descobrir através 
da qual o BPA actua, e uma nova verificação da expressão do Bax foi realizada, sendo 
que apenas o inibidor selectivo BMS-345541 causou uma diminuição da expressão do 
Bax, sugerindo uma acção que passa através no factor de transcrição NFkb. 
Pudemos concluir que os resultados obtidos são consistentes com a associação 
entre a exposição ao BPA e o desenvolvimento de diabetes que se encontra descrito na 
literatura uma vez que a exposição a uma dose de 1 nM de BPA promoveu a apoptose 
em β-Islets de murganho. 
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1.1 - Toxicogenomics 
The ability to discern the mechanisms of toxicity that are related to health issues 
is an important challenge faced by scientists, public-health decision makers and 
regulatory authorities, whose aim, is to protect humans and the environment from 
exposures to hazardous drugs, chemicals and environmental stressors (Waters and 
Fostel, 2004). 
The term ‘toxic agent’ can be defined as any substance that causes harmful 
effects on living organisms, but in general, such hazardous effects are substantially 
dependent on the chemical’s exposure level (Kiyosawa et al, 2010). 
Toxicology - the study of poisons – is focused on the substances and exposures 
that cause adverse effects in living organisms. A vital part of these studies is the 
empirical and contextual characterization of adverse effects at the level of the organism, 
the tissue, the cell and intracellular molecular systems. Therefore, traditional studies in 
toxicology measure the effect of an agent on an organism’s food consumption and 
digestion, on its body and organ weight, on a microscopic histopathology, and on cell 
viability, immortalization, necrosis and apoptosis (Waters and Fostel, 2004). 
Nowadays, traditional toxicity testing approaches are inadequate to meet the 
challenge of current toxicity assessment requirements. Tens of thousands of chemicals 
are used annually in industry that have no toxicological data associated with them, and 
this number is increasing (Vulpe and North, 2010). During the past two decades, and 
especially since the publication of the sequence of the human genome, rapid and 
unprecedented advances in molecular biology have been achieved. This resulted in a 
dramatic increase of our knowledge in the field of genomics, (Gatzidou et al, 2007) 
which is defined as the systematic study on a whole-genome scale for the identification 
of genetic contributions to human conditions, (Zhang et al, 2011) using other words 
genomics represents the study of the structure, function and nucleotide sequences of 
component genes of the genome, in order to determine how genes interact and influence 
biological pathways, networks and cellular physiology. The link between conventional 
toxicological research and functional genomics resulted in the emergence of 
toxicogenomics (Gatzidou et al, 2007). 
Toxicogenomics is defined as “the application of global mRNA, protein and 
metabolites analysis related- technologies to study the effects of hazards on organisms”, 
therefore it intends to studies the interactions between the genome and the adverse 
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biological effects caused by exogenous agents such as environmental stressors, toxins, 
drugs and chemicals (Vulpe and North 2010). These technologies can be applied into 
two broad and overlapping classes: mechanistic or investigative, and predictive 
toxicology. Mechanistic or investigative toxicology is the field of toxicology focused on 
the biochemical and biological responses in a particular type of toxicity giving 
important information for the risk assessment of different compounds; it is used to 
characterize toxicological findings at the molecular level, generate hypotheses about the 
mechanism of toxicity, identify potential safety biomarkers, contribute to the elucidation 
of species specificity and at the end also to support the risk assessment of new chemical 
entities. Predictive toxicology, in the present context, refers to the field of toxicology 
focused on the identification of a compound to be potentially toxic; in addiction this 
term is often used to refer to studies that attempt to extrapolate toxic reactions from 
preclinical species to humans (Gatzidou et al, 2007; Sahu, 2008; Semizarov and 
Blomme, 2008). 
This field has three principal goals: to understand the relationship between 
environmental stress and human disease susceptibility; to identify useful biomarkers of 
disease and exposure to toxic substances; and to elucidate the molecular mechanisms of 
toxicity (Waters and Fostel, 2004). 
Chemical-specific changes in the transcriptome profile leads to changes in the 
proteome profile, the metabolome profile and eventually the tissue-level phenotypes. 
Thus, it is natural that the transcriptome profile would contain a significant degree of 
information for biological conditions at the moment, which may lead to a profound 
understanding of chemical-induced molecular perturbations (Kiyosawa et al, 2010).  
1.2- Endocrine system  
The term endocrine is derived from the Greek words endo, meaning within, and 
crino, to separate. The term implies that cells of endocrine glands secret chemical 
signals that influence tissues that are separated from endocrine glands by some distance. 
(Seeley et al, 2004) 
The endocrine system is a complex collection of hormone producing glands, 
which differ from most of the other organ systems of the body due to the fact that the 
various glands are not anatomically continuous. However, they do form a system in the 
functional sense and are able to co-ordinate the control and regulation of a multitude of 
biochemical processes that occur in the body, such as metabolism, growth, 
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cardiovascular function, and digestion, as well as more specialized functions such as 
behaviour, sexual differentiation during embryogenesis, sexual maturation during 
puberty, and reproduction in adulthood. The endocrine glands consist of pineal, 
pituitary, thyroid, parathyroid, thymus, adrenals, pancreas, ovaries (female), and testes 
(males), in addition to minor glands distributed in multiple tissues (Harvey and 
Cockburn, 1999; Vander et al, 2001; Naciff and Daston, 2004). 
 
Figure  1 - Model representative of the endocrine systems (Diamanti-Kandarakis et al, 2009) 
These glands produce hormones, term derived from the Greek hormon, meaning 
to set in motion. A hormone is traditionally defined as a chemical signal or ligand that is 
produced in minute amounts by a collection of cells, is secreted into interstitial spaces, 
and enters the circulatory system, where it is transported some distance in order to act 
an influence, in a specific manner, those tissues, denominated target tissues (Seeley et 
al, 2004). Hormones are secreted by endocrine glands when there is a need for them in 
their target organs. Therefore, the cells of endocrine glands must respond to changes in 
blood or perhaps to the presence of other hormones in the blood. These stimuli are the 
information they use to increase or decrease secretion of their own hormones, 
consequently, when a hormone brings about its effect, the stimulus is reversed, and 
secretion of the hormone decreases until the stimulus reoccurs, being this denominated a 
negative feedback mechanism (Scalon and Sanders, 2007). 
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 Endogenous hormones act through several mechanisms. The classical 
mechanism of action for steroid hormones such as estrogens, androgens, thyroid and 
progesterone involves binding of the hormone to its receptor, the interaction of this 
hormone-receptor complex with other cofactor in a cell, and the activation or 
inactivation of transcription of a target gene. In addition, hormone signalling also 
involves the synthesis, degradation, or inactivation of hormones by specific enzymes, 
any or all of which may be targeted by endocrine disruptor compounds (EDCs). 
Labelling a chemical as an ‘‘endocrine disruptor’’ involves using the term to very 
broadly cover disruption of the synthesis and transport of chemical messengers 
(autocrine, paracrine, endocrine, neurotransmitters), as well as their intracellular 
signalling pathways and receptor systems that regulate cell function and intercellular 
communication. (Naciff and Daston, 2004; Gore, 2007; Vom Saal et al, 2012). 
1.3 – The Pancreas 
The pancreas is both an exocrine and endocrine gland, it lies behind the 
peritoneum between the greater curvature of the stomach and the duodenum. It is a 15 
cm long elongated structure and weighs approximately 85 to 100g. The exocrine portion 
consists of acini, which produce pancreatic juice, and a duct system that carries the 
pancreatic juice to the small intestine and the endocrine portion, consisting of pancreatic 
islets that are able to produce hormones that enter the circulatory system. The pancreatic 
islets are dispersed among the ducts and acini of the pancreas, with quantities ranging 
from 500,000 to 1 million, are able to secrete at least five hormones and paracrine 
products, the most important of which are insulin, glucagon, and somatostatin. (Saladin, 
2003; Seeley, et al 2004). 
Figure  2 - Simplified mechanism of the role and targets of insulin (Seeley et al, 2003) 
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1.3.1 - Islets of Langerhans  
The islets of Langerhans or pancreatic islets are scattered throughout the 
pancreas and constitute about 1%-2% of the pancreas and contain several different cell 
types – including endocrine cells, endothelial cells, nerves and fibroblasts – a range in 
size from just a few islet cells to complex several thousand islet cells with a diameter up 
to 300-400 μm. Each islet containing between 1000 and 3000 cells and contain insulin-
producing beta cells, glucagon-producing alpha cells, somatostatin-producing δ-cells, 
pancreatic polypeptide-producing PP cells and ghrelin-producing epsilon cells 
(Costanzo, 2006; Seino and Bell, 2007).  
 
 
Figure  3 - Struture and morphology of the β-Islet (Seeley et al, 2003) 
 
The main function of pancreatic β-cells is the biosynthesis and release of insulin, 
which is controlled by many signaling molecules including neurotransmitters, hormones 
and nutrients, among which glucose is the most important. Indeed β-cells function as 
glucose sensors with the crucial task of precisely adjusting insulin release to blood 
glucose levels, a process in which mitochondria play a central role. Altered nutrient 
storage and usage, hyperglycemia, and ultimately diabetes, appear when loss or 
dysfunction of the β-cells fall below a critical threshold (Nadal et al, 2009; Supale et al, 
2012) 
 
1.4 – Regulation of Blood Glucose by insulin  
The regulation of blood glucose levels requires insulin. Blood glucose levels can 
increase dramatically when too little insulin is secreted or when insulin receptors do not 
respond to it; consequently the pancreas is a vital organ for regulating glucose 
metabolism in the body. Glucose is transported into β-cells, induced by the increase of 
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plasma glucose levels and leads to insulin exocytosis, which manipulates the glucose 
levels (Han and Park, 2011). The secretory response of β-cells depends on their 
electrical activity. The β-cell membrane contains specific transporters for glucose, 
which promote his entering into the cell by facilitated diffusion, once inside the cell, it’s 
phosphorylated to glucose-6-phosphate by glucokinase, thereby initiating glycolysis 
and, subsequently, oxidized. Thereafter, mitochondrial metabolism generates ATP, one 
of the products of this oxidation step, which appears to be the key factor that regulates 
insulin secretion. K
+
 channels in the β-cell membrane are regulated by changes in ATP 
levels, when there is an increase (inside the β cell), the K+ channels close, which 
depolarizes the β-cell membrane. In the β-cell membrane Ca2+ channels are also present 
and they are regulated by changes in voltage, becoming open through depolarization 
and close through hyperpolarization. When depolarization occurs, Ca
2+
 channels open 
and, subsequently Ca
2+
 flows into the β cell. Finally, the increases in intracellular Ca2+ 
concentration cause exocytosis of the insulin-containing secretory granules, with the 
insulin being secreted into pancreatic venous blood and then delivered to the systemic 
circulation. Relevantly, additional signals are necessary to reproduce the sustained 
secretion elicited by glucose. They participate in the amplifying pathway formerly 
referred to as the KATP-channel-independent stimulation of insulin secretion. In contrast 
to the transient secretion induced by Ca
2+
 raising agents, the sustained insulin release 
depends on the generation of metabolic factors. C peptide is secreted in equimolar 
amounts with insulin and is excreted unchanged in the urine. Therefore, the excretion 
rate of C peptide can be used to assess and monitor endogenous β-cell function 
(Costanzo, 2007; Nadal et al, 2009; Maechler et al, 2010) 
1.5 - Mitochondria 
Mitochondria are key organelles that generate the largest part of cellular ATP and 
represent the central crossroad of metabolic pathways. (Maechler et al, 2010). The 
metabolic profiling of β-cell identified mitochondria as key components for their 
function, as sensors and as generators of metabolic signals controlling insulin secretion 
(Maechler et al, 2010). In most tissues, cytosolic conversion of pyruvate to lactate by 
lactate dehydrogenase ensures the NADH oxidation, however in β-cells this task is 
performed mainly through mitochondrial NADH shuttles, transferring glycolysis-
derived electrons to mitochondria, this favors the transfer of pyruvate into the 
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mitochondria, which is followed by a catabolism of glucose-derived pyruvate that 
induces mitochondrial activation and subsequently generation of ATP (Supale et al, 
2012). 
A unifying theme is that production of reactive oxygen species (ROS) induced 
by metabolic stress represents a common pathway of injury in the cascade of events that 
ultimately results in β-cell failure (Ma et al, 2012) and mitochondrial electron transport 
chain is the major site of ROS production within the cell. ROS formation is coupled 
with this electron transportation as a by-product of normal mitochondrial respiration 
through the one-electron reduction of molecular oxygen; furthermore mitochondria are 
also one of the primary targets of ROS. The mitochondrial genome is vulnerable to 
oxidative stress and consecutive susceptible to damages are more extensive than those 
in nuclear DNA due to the lack of protective histones and low repair mechanisms 
(Maechler et al, 2010; Ma et al, 2012). Short transient exposure to oxidative stress is 
sufficient to impair glucose-stimulated insulin secretion in pancreatic islets, ROS may 
affect insulin-secreting cells, resulting in mitochondrial inactivation, thereby 
interrupting transduction of signals and as such affecting insulin secretion, in fact it was 
observed that one single acute oxidative stress may induce β-cell dysfunction, in a 
lasting over days manner, a fact that can be explained by persistent damages in 
mitochondrial components, accompanied by subsequent generation of endogenous ROS 
of mitochondrial origin (Maechler et al, 2010). 
 
1.6 - Animal Model – The Mouse 
In the mouse the pancreas is described as a diffuse pink gland located between 
stomach, duodenum and colon. It extends posteriorly in the duodenal loop, lying close 
to the mesenteric attachment. It is divided into irregular lobes and lobules. Several 
excretory ducts are present, some joining the bile duct where this crosses the pancreas 
before entering the duodenum. It is both an exocrine and endocrine gland, the first is a 
complex tubulealveolar gland lacking a connective tissue capsule but surrounded by 
loose vascular connective tissue of the mesentery and separated into lobes and lobules 
by septa of loose fibroelastic tissue and the endocrine portions is constituted by the 
islets of Langerhans, are always closely associated with the septal ducts and blood 
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vessels. (Green, 1968) The percentage of the different cell subpopulations and the islet 
cytoarchitecture vary between species. In rodent islets, β-cells are the most abundant, 
60–80% of the total number of cells and α-cells constitute 15–20%; in human islets the 
proportion varies, with the percentage of α-cells being higher (35–45%) and the β-cell 
percentage lower (55–65%). Moreover, in humans α and β-cells are distributed evenly 
throughout the islet, suggesting that paracrine interactions between both types of cells 
may be vital, on the other hand in rodents β-cells constitute the core of the islets while 
non β-cells are distributed in the periphery (Nadal et al, 2009). 
 
1.7 - Endocrine Disruption 
1.7.1 - EDCs 
 
An endocrine-disrupting compound was defined by the U.S. Environmental 
Protection Agency (EPA) a “an exogenous agent that interferes with synthesis, 
secretion, transport, metabolism, binding action, or elimination of natural blood-borne 
hormones that are present in the body and are responsible for homeostasis, reproduction 
and developmental process.”.  
It is well recognized that EDCs pose a potential risk affecting both wildlife and 
human health on a global scale. The issue of endocrine disruption has been something 
of a cause célèbre since it was first identified as an issue about 25 years ago. Few 
scientists had previously suspected that certain synthetic chemicals might be able to 
interfere with the workings of the endocrine system at low concentrations. However, in 
the mid-1990s, Theo Colborn and others brought this subject to the attention of a wide 
audience when it became clear that many different wildlife species were experiencing 
effects that were attributable to damaged hormone signalling (Matthiessen, 2013).  
The group of molecules identified as endocrine disruptors is highly 
heterogeneous and includes synthetic chemicals used as industrial solvents/lubricants 
and their byproducts [polychlorinated biphenyls (PCBs), polybrominated biphenyls 
(PBBs), dioxins], plastics [Bisphenol A (BPA)], plasticizers (phtalates), pesticides 
[methoxychlor, chlorpyrifos, dichlorodiphenyltricholoethane (DDT)], fungicides 
(vinclozolin), and pharmaceutical agents [diethylstillbestrol (DES)] (Diamanti-
Kandarakis et al, 2009) and according to the Chemical Abstracts Service (CAS) the 
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numbers of synthetic chemicals, such as pharmaceuticals, cosmetics, pesticides, food 
additives and industrial chemicals have increased dramatically over the last few decades 
(Cheng et al, 2013). As of December 6, 2012, there were 70 million chemicals 
registered (www.cas.org). The most commonly studied EDCs are 
dichlorodiphenyltrichloroethane (DDT), polychlorinated biphenyls (PCBs), 
polybrominated diphenyl ethers (PBDEs), phthalates, and bisphenol A (BPA) (Bonefeld-
Jorgensen et al, 2007; Bernal and Jirtle, 2010).  
At the environmental level, wildlife is vulnerable to the endocrine disrupting 
effects of EDCs. Effects linked to endocrine disruption have been largely noted in 
invertebrates, reptiles, fish, birds and mammals and the human species. The species, at 
the top of the food chain are particularly exposed to health risks from environmental 
polluting chemicals owing to bioaccumulation and biomagnification of such substances 
in the food chain. Drinking or ingesting contaminated water or food, breathing 
contaminated air or contacting contaminated soil represent the main pathways of 
exposure to environmental polluting chemicals, a number of EDCs appear in drinking 
water as a result of effluent from manufacturing plants and agricultural centers entering 
into streams. Some EDCs are present in personal hygiene products as well as in food 
and beverage containers (Mnif et al, 2011; Bechi et al, 2013; Rogers et al, 2013). 
Furthermore, several EDCs were designed to have long half-lives and although this was 
beneficial for their industrial use, it has turned out to be quite detrimental to wildlife and 
humans. In general, EDCs are also considered to accumulate in the body because of 
their chemical stability. Since these substances do not decay easily, may not be 
metabolized, or may be metabolized into more toxic compounds than the parent 
molecule, even substances that were banned decades ago, remain in high levels in the 
environment, and they can be detected as part of the body burden of virtually every 
tested individual, animal or human (Diamanti-Kandarakis et al, 2009; Sasaya et al, 
2012). 
 
1.7.2 – Epidemiological evidences  
There are several health problems worldwide with postulated association to the 
exposure to EDCs: decreased sperm counts, increased incidence of hypospadias and 
cryptorchidism, altered birth sex ratios, miscarriage, increased incidence of cancer, 
altered development, brain and behaviour defects, impaired immune function, attention 
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deficit hyperactivity disorder, hyper allergic diseases, asthma, obesity, heart disease and 
type two diabetes. Epidemiological evidence that human reproductive health is 
declining, particularly in Western nations, continues to mount, sperm counts in Western 
countries appear to have declined by half in the past 50 years and female fecundity is 
declining, even among young women. Within the United States, median age at 
menarche, breast development, and sexual precocity has steadily advanced and similar 
trends have been noted in Europe and among children adopted from developing 
countries by Western parents. The cause is likely complex and multi-faceted, but 
rapidity of the increase in reproductive and behavioral disorders suggests an 
environmental component. Whether or not endocrine disrupting compounds (EDCs) 
could be a contributing factor remains the subject of intense scrutiny and other 
determinants such as diet, stress, and body weight likely also play a role (Safe, 2005; 
Diamanti-Kandarakis et al, 2009; Myers et al, 2009; Patisaul and Adewale, 2009; Bernal 
and Jirtle, 2010).  
 
1.8 - Molecular Mechanisms of Action 
 
The molecular mechanisms of this endocrine disruption, however, remain poorly 
understood (Bechi et al, 2013). Effects of these compounds are known to occur in 
multiple endocrine axes such as estrogen, androgen, thyroid hormone, prolactin and 
insulin systems. The putative effects are wide ranging and the mechanisms of action are 
concomitantly diverse (Diamanti-Kandarakis et al, 2009; Ding et al, 2010). A large 
number of these EDCs act via the estrogen receptor (ER), imperfectly mimicking and 
interfering with the physiologic actions of endogenous estrogens. Xenoestrogens (XEs) 
can bind to ERs , the complex recognizes DNA response elements and alters gene 
expression; in the non-genomic pathway XEs can bind to membrane-bound ERs and 
rapidly initiate signaling cascades that culminate in kinase and phosphatase activations, 
ultimately influencing cellular function by post-translational modifications of a variety 
of proteins (Viñas et al, 2012).  
Estrogens and xenoestrogens exert a great variety of actions in almost every cell 
type and through diverse cellular and molecular pathways (Ropero et al, 2008). EDCs 
were originally thought to exert actions primarily through nuclear hormone receptors 
(ERs), androgen receptors (ARs), progesterone receptors, thyroid receptors (TRs) and 
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retinoid receptors, nonetheless today scientific research shows that the mechanisms are 
much broader than originally recognized (Schug et al, 2011). As example divergent 
pathways including, but not limited to peroxisome proliferator-activated receptor γ and 
actions through other nuclear receptors, steroidogenic enzymes, neurotransmitter 
receptors and systems, and the mimic the natural hormone’s action (agonist action), 
furthermore these compounds may bind to these receptors without activating them, 
blocking the receptors and inhibiting their action, and on the other hand, EDCs may 
interfere with the synthesis, transport, metabolism and elimination of hormones, thereby 
decreasing the concentration of natural hormones. In addition to these endocrine active 
properties, some EDCs have been shown to disrupt epigenomic programming. Thus, 
EDCs act via nuclear receptors, non-nuclear steroid hormone receptors, non-steroid 
receptors, and orphan receptors, transcriptional coactivators, enzymatic pathways 
involved in steroid biosynthesis or metabolism, and numerous other mechanisms that 
converge upon endocrine and reproductive systems (Diamanti-Kandarakis et al, 2009; 
Bernal and Jirtle, 2010; Mnif et al, 2011). Through these interactions and acting as 
agonists or antagonists, EDCs are able to alter the activity of response elements of 
genes, block natural hormones from binding to their receptors, or in some cases increase 
the perceived amount of endogenous hormone in the body by acting as a hormone 
mimic to its receptor. The modifications of the pattern of gene expression on particular 
cell types, from target tissues or organs as response to a toxic exposure can be 
highlighted. Some chemicals elicit toxic responses by first damaging cellular 
components or DNA, which provoke alterations in the expression of appropriate repair 
genes, while that others modulate endocrine systems or cellular replication disturb 
directly by triggering signal transduction systems, either at the membrane or in the 
nucleus, leading to alteration of gene expression (Naciff and Daston, 2004; Rogers et al, 
2012).  
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A number of issues have proven to be key concepts to a full understanding of 
mechanisms of action and consequences of exposure to EDCs: 
 Age at exposure - Exposure of an adult to an EDC may 
have very different consequences from exposure to a developing fetus or 
infant. In fact, the field of endocrine disruption has embraced the 
terminology “the fetal basis of adult disease” to describe interactions of 
the environment of a developing organism and the external environment 
with the individual’s genes to determine the propensity of that individual 
to develop a disease or dysfunction later in life. 
Figure  4 - Representation of the interactions between endocrine disruptors and receptor 
function. (A) EDCs can compete with Natural hormones for receptor binding. (B) 
Binding of EDCs can result in altered downstream signaling. (C) EDCs may bind 
unbound receptors while natural hormones are also bound which results in agonistic or 
antagonistic downstream signaling (Rogers et al, 2013) 
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 Latency from exposure - The consequences of 
developmental exposure may not be immediately apparent early in life 
but may be manifested in adulthood or during aging. 
 
 Cocktail effects - Contamination of environments is rarely 
due to a single compound. Furthermore, effects of different classes of 
EDCs may be additive or even synergistic. 
 
 Transgenerational, epigenetic effects - EDCs may affect 
not only the exposed individual but also subsequent generations. Recent 
evidence suggests that the mechanism of transmission may in some cases 
involve the germline and may be non-genomic. That is, transmitted 
effects may not be due to mutation of the DNA sequence, but rather due 
to modifications of factors that regulate gene expression such as DNA 
methylation and histone acetylation. 
 
 Nontraditional dose-response dynamics - Even 
infinitesimally low levels of exposure, indeed any level of exposure at 
all, may cause endocrine or reproductive abnormalities, particularly if 
exposure occurs during a critical developmental window. Surprisingly, 
low doses may even exert more potent effects than higher doses. EDCs 
may exert nontraditional dose-response curves, such as inverted-U or U-
shaped curves. 
 
(Diamanti-Kandarakis et al, 2009) 
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1.9 -Bisphenol A 
1.9.1 - BPA 
 
BPA (2, 2-bis (4-hydroxyphenyl) propane) is a small (228 Da) molecule which is 
used as a monomer in polymerization reaction to produce polycarbonate plastics, epoxy 
resins and other polymer materials for manufacturing plastic utensils and is among the 
highest-production-volume chemicals in the world, with an annual production of over 2 
million tonnes (Ben-Jonathan et al, 2009; Ryan et al, 2010; Lam et al, 2011; Gong et al, 
2013; Molina et al, 2013). BPA is formed by two phenol functional groups, and it is 
prepared by the combination of two equivalents of phenol with one equivalent of 
acetone, it was first synthesized by A. P. Dian in in 1891 and was later investigated in 
the 1930s during the search for synthetic estrogens (Vandenberg et al, 2009) 
 BPA is widely used in the production of packaging for food and drinks, paints, 
adhesives, drinking water pipe linings, dental sealants, flame-retardant, medical tubing, 
toys and eyeglass lenses (Qin et al, 2013; Ribeiro-Varandas, 2013; Teng et al, 2013). In 
a process commonly referred to as “leaching”, BPA seeps into the contents of various 
food and water packages and into dust particles, providing ample entry ways for BPA 
into physiological systems of animals and humans. Moreover BPA is contained in items 
that we come in contact at home and in the workplace including the coating of CDs, 
DVDs, electrical and electronic equipment, automobiles, sports safety equipment, 
recycled paper and carbonless paper, nevertheless humans are exposed to BPA mainly 
through oral and inhalation routes. 
1.9.2 - Leaching 
Numerous studies found that BPA leaches from polycarbonate baby bottles and 
reusable water bottles. Other polycarbonate containers intended to be used as reusable 
food containers, food-contact items such as polyvinyl chloride stretch films, and some 
paper and card- board used as food containers have been examined for their BPA 
content. Metallic food cans are protected from rusting and corrosion by the application 
of epoxy resins as inner coatings. Many of these resins are synthesized by the 
condensation of BPA with epichlorhydrin to create BPA diglycidyl ether. The relevant 
problem arises from factors as the incomplete polymerization, the aging, heating and 
contact with acids and bases, including those commonly found in cleaning supplies and 
detergents, that may cause the BPA polymers to break apart, and as such thing happens, 
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residual BPA leaches and has the potential to contaminate stored foods (Vanderberg et 
al, 2009; Rubin, 2011; Gong et al, 2013; Jayashree et al, 2013). 
Several studies show that BPA is released from consumer products leading to 
detectable levels of BPA in food, drinking water, waste water, air and dust. A 
comprehensive, cross-sectional study of dust, indoor and outdoor air, and solid and 
liquid food in preschool-aged children suggested that dietary sources constitute 99% of 
BPA exposure. Other studies identified BPA in human serum, urine, amniotic fluid, 
umbilical cord blood, placental and adipose tissue and milk of lactating mothers, even 
though at varying levels. BPA is rapidly excreted in urine, with a half-life in the range of 
4 to 43 hours, however, since BPA is a lipophilic compound it can also accumulate in 
fat, with detectable levels found in 50% of breast adipose tissue samples from women, 
suggesting that the compound accumulates in fat and other physiologic compartments. 
(Bondesson et al, 2009; Diamanti-Kandarakis et al, 2009; Huc et al, 2012, Trasande et 
al, 2012). 
Given the prevalence of BPA in our environment, it is not surprising that 
measurable levels have been detected in the majority of individuals examined to date. 
Measurements by the Centers for Disease Control (CDC) revealed detectable levels of 
BPA in the urine samples of 92.6% of more than 2500 participants of the cross sectional 
NHANES (National Health and Nutrition Examination Survey) study. The adjusted 
mean BPA levels reported were 4.5 ng/ml in children (6–11 years of age), 3.0 ng/ml in 
adolescents (12–19 years of age) and 2.5 ng/ml in adults with over 20 years old (Ruby 
and Soto, 2011). BPA metabolites were also found in more than 90% of the urine 
samples collected from the general populations of the United States and Italy, and 
estimated to be present in 95% of the United States citizens with concentrations in 
human serum ranging from 0.2 to 1.6 ng/mL (0.88–7.0 nM) (Huc et al, 2012; Teng et al, 
2013), another study has identified the strong presence of BPA and in the blood samples 
of most Hong Kong citizens, with a mean concentration of 0.95 ng/mL (4.1 nM) (Wan 
et al 2013). 
Estrogens and xenoestrogens exert a great variety of actions in almost every cell 
type and through diverse cellular and molecular pathways and BPA has well 
characterized estrogenic and other endocrine disrupting activities that are mediated via 
multiple molecular mechanisms. The core structure of BPA resembles that of natural 
17β-estradiol (E2) (Le et al, 2008; Ropero et al, 2008; Sheng et al, 2013) 
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1.10 - LOAEL 
Concerning the potential risk of this compound, in the 1980s the lowest-
observable-adverse effect-level (LOAEL) for BPA was determined at 50mg/kg bw/day, 
and the Environmental Protection Agency (EPA) calculated a ‘reference dose’’ or safe 
dose of 50 µg/kg bw/day in a series of studies in which the changes of body weight in 
animals fed diets containing BPA were analyzed (Alonso-Magdalena at, 2012). The 
LOAEL for BPA was established in a 2 year carcinogenesis study conducted in adult 
rodents exposed daily to high doses of BPA. The established LOAEL was then divided 
by an uncertainty factor of 1000, in order to provide a safety margin below the 
permitted daily exposure limits. Therefore, the first safety standard set by the EPA in 
1988 and adapted by the FDA as a reference dose for BPA was calculated to be 50 
µg/kg BW/day. This reference dose remains the current safety standard for BPA today 
despite new knowledge about BPA, including the numerous reports of non-monotonic 
dose response effects of BPA, and despite the numerous scientific evidence supports that 
BPA can interfere with the endocrine signaling pathways at doses below the calculated 
safe dose (Rubin, 2011; Alonso-Magdalena at, 2012). 
1.11 – Associated Dysfunctions 
BPA exposure is associated with multiple diseases within multiple biological 
systems. Various disorders can be highlighted, BPA is able to accelerate growth and 
puberty, alter the ovarian cycle in females, interfere with embryonic development, and 
to induce aneuploidy, it has harmful effects on the multipotent neural progenitor and 
increases depression-like behaviour in rats. Moreover, a relationship between BPA 
blood levels, obesity, polycystic ovary syndrome, repeated miscarriage, and endometrial 
hyperplasia has been found. Exposure to BPA has also been correlated with the 
incidence of diverse types of tumors (Dong et al, 2011; Pupo et al, 2012). A study from 
A B 
Figure  5 - Chemical Structure of BPA (A) and Estradiol (B) Dong et al, 2011 
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Alonso-Magdalena suggest that the endocrine disruptor BPA should be evaluated as a 
possible risk factor for gestational diabetes, type 2 diabetes, and cardiovascular disease 
associated with metabolic syndrome (Alonso-Magdalena et al, 2010). In vivo studies 
using much lower doses of BPA than the LOAEL have shown that it affects sexual 
maturation, induces a decrease in daily sperm count and fertility, disrupts chromosome 
alignment, affects synaptogenesis and it rapidly increases plasma insulin, altering blood 
glucose concentration (Alonso-Magdalena et al, 2006). Studies regarding Xenopus 
tadpoles and Japanese medaka showed skewed sex ratios, with tendency of 
feminization upon exposition to BPA, suggesting that it may act as an endocrine 
disruptor (Pupo et al, 2012; Rogers et al, 2013). 
 
The effects of BPA display a discrepancy with dose and time of exposure 
variations. Some of the effects due to developmental exposure to levels of BPA at or 
below the LOAEL or the human safe dose include: altered time of puberty; altered 
estrogenic cycles; prostate changes; altered mammary gland development and evidence 
of intraductal hyperplasia and preneoplastic mammary gland lesions in adulthood; 
changes in the uterus and ovary; alterations in brain sexual dimorphisms; additional 
changes in the brain and in brain steroid receptor levels and receptor transcripts; 
changes in behavior including reports of hyperactivity; increased aggressiveness; altered 
socio-sexual behavior; altered cognitive and anxiolytic behaviors; increased 
susceptibility to drugs of addiction; altered body weight and body composition and 
altered glucose homeostasis (Rubin, 2011). 
Meaningfully, it has been argued that the shape of the dose-response curve, 
particularly for chemicals with hormonal activity, is very different at high 
concentrations than the one obtained at low concentrations, BPA often exhibits a lack of 
linear dose-dependent relationship, showing instead U-shaped or inverted U-shaped 
curves. Consequently, extrapolation from an action or lack of action, of BPA at high 
doses to its presumed bioactivity at low doses is unwarranted (Naciff and Daston, 2004; 
Hugo et al, 2008). For many years, when assessing the effects of possible endocrine 
disruptors, toxicologists have relied on the principle that “the dose makes the poison,” 
implying that higher doses were expected to cause greater harm. Thus, effects that are 
not seen at high doses are not expected at low doses. In contrast, multiple studies have 
found that neither the threshold nor the linear non-threshold models are applicable to the 
responses of hormones in which biphasic dose responses have been observed for many 
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different endpoints at many levels of organization. These U-shaped and inverted U-
shaped dose response curves are considered “non monotonic” and are used as evidence 
that very low doses of natural and synthetic hormones can affect endpoints such as cell 
proliferation and organ development (Vandenberg et al 2009; Schug et al, 2011). Non 
monotonic dose–response curves result from multiple mechanisms. Hormones and 
hormone-mimicking chemicals act through receptors in target cells. Very low doses can 
stimulate the production of more receptors (receptor up-regulation), resulting in an 
increase in responses, whereas higher doses (within the typical toxicological range of 
chemical testing) can inhibit receptors (receptor down-regulation), resulting in a 
decrease in responses (Myers et al, 2009).  
Despite the controversy surrounding the “low dose” concept, there are several 
reasons why dose response curves to toxicants may be non-monotonic, the induction of 
metabolizing enzymes, conjugation of substrates, down regulation of receptors at higher 
hormone levels and also the integration of two or more monotonic dose response curves 
that occur through different pathways affecting a common endpoint with opposing 
effects. Additionally, adaptive responses through complex cell signalling pathways and 
feedback mechanisms could cause non-monotonic effects that are inconsistent with 
traditional dose-response curves (Schug et al, 2011).  
NMDR curves have been observed after exposure of cultured cells to BPA. For 
instance, the response of GH3/B6 pituitary cells to BPA followed a U-shaped NMDR 
curve, where doses of 10
-12
M, 10
-11
M, and 10
-8
 M elicited significant responses and 
doses of 10
-10
M and 10
-9 
M did not. LNCaP prostate cancer cells responded to BPA in a 
similar manner with maximal proliferation induced by 10
-9
 M. Additionally, BPA 
inhibited adiponectin secretion from human adipose explants with a U-shaped NMDR 
curve; concentrations of 10
-10
 M and 10
-9
 M inhibited release, whereas doses of 10
-8
 M 
and 10
-7
 M were indistinguishable from unexposed controls (Vandenberg et al 2009). 
Another example of a clear ‘U’-shaped dose-response curve was found treating breast, 
subcutaneous and visceral adipose tissue explants as well as isolated mature adipocytes 
with BPA, in the same study it was reported that at 1 and 10mM concentrations BPA 
was able to inhibit adiponectin release and was also found to a stimulate IL-6 and TNFα 
release, two inflammatory cytokines, considering that low circulating adiponectin levels 
and elevated inflammatory cytokines are strongly associated with increased risks of 
obesity-related diseases (Ben-Jonathan et al, 2009). It is also described that BPA is able 
to enter fibroblasts in the differentiation process and enhance the adipocyte conversion 
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in combination with insulin suggesting that in vivo prolonged exposure to BPA might 
increase body fat mass and as such be involved the development of obesity (Masuno et 
al, 2002), it also influences 3T3-F442A adipocytes by increasing basal and insulin 
stimulated glucose transport (Sakurai et al, 2004) Pancreatic islet cells exposed to BPA 
have their insulin release affected, displaying an inverted U-shaped NMDR curve where 
only doses of 10
-9
 M and 10
-10
 M significantly increase insulin release (Vandenberg et al 
2009).  
 
1.12 - BPA and diabetes 
 Obesity increased in prevalence to a considerable extent during the last half of 
the 20
th
 century in both adults and children (Elobeid and Allison, 2008). It has 
deleterious effects on human health by increasing the risk of associated metabolic 
abnormalities such as insulin resistance, hyperinsulinemia, hypertension, and 
dislipidemia, all components of the metabolic syndrome which constitute, in turn, one 
of the major risk factors for the development of among other pathologies, diabetes 
mellitus type 2 (Diamanti-Kandarakis et al, 2009).  
 Recent studies, especially regarding model-animals suggest that BPA exposure 
may have a significant role in weight gain, contribution to the development of obesity, 
insulin resistance, and subsequently have relevance in the development of diabetes 
mellitus (Shankar and Teppala, 2011). In experimental studies, it has been shown to 
interfere and disrupt metabolic mechanisms, suggesting that it may have a relevant role 
in the body mass increase at environmentally relevant doses (Trasand et al, 2012) 
A multitude of factors will influence whether an individual develops obesity, as 
such, genetic, nutritional and environmental factors are known to impact hunger and 
satiety, basal metabolic rate, carbohydrate and lipid flux, and the regulation of adipocyte 
proliferation and differentiation and developmental programming of metabolic set 
points (Grün and Blumberg, 2009) and although most attention has focused on high 
caloric diet and sedentary lifestyle as the root causes, the role of environmental factors 
is gaining credence (Hugo et al, 2008).  
Recent epidemiological evidence suggests a correlation between BPA and the 
occurrence of diabetes. A study performed in China, regarding 3400 subjects, showed a 
strong association between urinary levels of BPA and diabetes, where an increase of 
37% of the incidence of diabetes was found in subjects where the concentration of BPA 
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was above 1,43 ng/ml , against a reference concentration equal or lower than 0,47ng/ml 
(Gong et al, 2013). Increasing levels of urinary BPA were also positively associated 
with metabolic syndrome in a representative sample of US adults, independently from 
factors as age, gender, race/ethnicity, smoking, alcohol intake, moderate physical 
activity levels and urinary creatine level (Teleppala et al, 2012). 
Relevantly, severe of the diabetes hallmarks that have correlations with impaired 
pancreatic β-cell function have been found in normal mice exposed to BPA (Gong et al, 
2013) and studies in rodents have also demonstrated that exposure to BPA elicits 
alterations in glucose homeostasis (Batista et al, 2012). Pancreatic islets are thought to 
play a key role in the pathophysiology of Type 1 and Type 2 diabetes through the failure 
of islet beta cells to secrete sufficient quantities of insulin to regulate blood glucose 
(Carter et al, 2009). 
 
 
1.13 - Associated Receptors 
 
BPA is a xenoestrogen, and its estrogenic effect alters pancreatic β-cell function 
and induces glucose intolerance and insulin resistance in male mice (Alonso-
Magdalena, 2010). There are many mechanisms proposed for the BPA action, it is well 
established that BPA can exert effects by binding at the nuclear steroid receptors, ERα 
and ERβ, induce estrogenic signals that modify estrogen-responsive gene expression.  
The estrogen receptors ERα and ERβ have been both involved in energy balance, 
although up to now, evidence points to ERα as the main mediator. BPA has an affinity 
approximately 1:2000 of that of 17β-E2 for ER and therefore it will activate ERs at 
concentrations within the micromolar level, which are higher than those commonly 
found in the environment. The role of ERs in the physiology of the endocrine pancreas 
is still greatly undetermined, although recent studies have contributed with important 
functional evidence. The effects of estradiol (E2) in some physiological aspects of the 
islet of Langerhans have been known for a long time. There is an influence in the 
plasma insulin levels which become increased in pregnant rats in response to increased 
levels of sex steroids. The presence of E2 at concentrations similar to those in 
pregnancy enhances insulin secretion in perfused rat pancreas, acting partly through 
ERα, protects pancreatic β-cells from apoptosis induced by oxidative stress. In human, 
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it contributes to the reversion of the effect of menopause on glucose and insulin 
metabolism, resulting in increased pancreatic insulin secretion as well as improved 
insulin resistance. Several membrane steroid receptors have been described, it was 
demonstrated that both1 nM concentration of 17β-E2 and BPA produced calcium-
dependent activation of CREB in mice pancreatic islets of Langerhans, evidencing that 
low-doses of BPA, can modulate gene transcription via an alternative pathway, 
functional “non-classical” membrane estrogen receptors (ncmER), independently from 
classical mechanism involving nuclear ERs (Quesada et al, 2002). Other receptors 
described include a membrane-bound form of ER similar to the nuclear ER (mER) and a 
transmembrane ER, called G protein-coupled receptor 30 (GPR30). BPA has been 
shown to bind to both mER and GPR30, and studies have determined that these 
membrane-bound receptors are capable of non- genomic steroid actions (Quesada et al, 
2002; Ropero et al, 2008; Vanderberg et al, 2009). 
The “non-classical membrane ER” (ncmER) has been described as capable of 
mediating actions at concentrations as low as 0.1nM of BPA in the endocrine pancreas. 
This action is also related to the activation of the transcription factor calcium- 
dependent cAMP-responsive element binding protein (CREB). BPA and estradiol were 
able to activate CREB with the same potency (Wetherill et al, 2007).  It is also reported 
that BPA interacts with and activates human PXR (pregnane X receptor), a nuclear 
receptor that functions as a regulator of xenobiotics, acting as a potent agonist (Sui et al, 
2012).  
 Xenoestrogens may also alter the ERs ability to recruit co-activators, a factor 
that may be important for differences in tissue- dependent responses (Vanderberg et al, 
2009). 
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Objectives 
 
Exposure to low levels of EDCs may be of concern. This is seemingly 
ubiquitous in today's environment, and EDCs are detectable in nearly all human blood 
samples. BPA is linked to a wide variety of endocrine dysfunction. BPA exposure 
increases the risk of mammary cancer, obesity, diabetes, and reproductive and 
neuroendocrine disorders. (Elobeid and Allison, 2008; Diamanti-Kandarakis et al, 2009) 
The endocrine disruption by BPA represents a real risk factor, and the studies regarding 
endocrine disruption conducted so far resulted in conflicting data. 
Therefore the overall objective of the project is to dissect the mechanism of 
endocrine disruption of BPA, in the regulation of beta cells activity using a 
toxicogenomic approach. 
 We specifically aimed to: evaluate the effect of BPA on Pancreatic Islets of 
Langerhans, mouse embryonic fibroblast (MEF) and hepatocytes, given the specific role 
that each of this cellular types may have in the homeostasis of the organism; Control the 
specificity of the effect for each cellular type; Evaluate the influence of BPA in the 
cellular viability and production of ATP; and determine the pathway through which BPA 
is capable of inducing the dead on β-Islets. 
 
 
 24 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter II - Material and Methods 
  
 Chapter II – Material and Methods  
25 
 
 
2.1 -Animal Model 
During the study C57/B6 mice (Biogem s.c.a.r.l., Ariano Irpino (AV), Italia.) 
were used given the animal experimentation background, more specifically the existent 
data related to the pancreatic influence from BPA and also the acceptance from the 
committee on internal animal care. 
 
2.2 - Isolation and purification of mouse β-Islets 
The primary goal of isolating pancreatic islets, whether for in vivo 
transplantation or in vitro studies, is to obtain viable purified islets that respond in a 
manner consistent with their function in vivo. The key elements of a successful islet 
isolation procedure are: enzymatically digesting the tissues connecting the islets to the 
exocrine tissue, separating islets from non-islet tissue, and culturing isolated islets in an 
environment that maintains cell viability (Carter el al, 2009). Primary cultures of mouse 
β-Islets were prepared as previously, described by Gotoh et al. 
Male C57/b6 mice were sacrificed by cervical dislocation, placed with the 
abdominal side facing and the skin was sterilized with ethanol 70%, afterwards an 
incision was made in order to expose the liver and intestines.  
 
Subsequently the ampulla was found and clamped in the duodenum wall to block the 
bile pathway to the duodenum. 
Figure  6 - Ex-Vivo Pancreatic perfusion : Exposing the 
common bile duct 
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The next and most delicate step, performed under the microscope, consisted in 
the insertion of a 5 mL syringe mounted with a 30G1/2-G needle into the common bile 
duct through the joint of the hepatic and cystic duct. As soon as approximately the 
middle of the common bile duct was reached, the pancreas was injected very slowly and 
carefully with 3mL of solution II.  
 
 
Figure  8 -  Ex-Vivo Pancreatic perfusion : 
Searching for the Clamp adequated place 
Figure  7 -  Ex-Vivo Pancreatic perfusion : 
Clamp placed 
Figure  9 - Ex-Vivo Pancreatic perfusion : 
The insertion of the needle 
 
 
Figure  10 - Ex-Vivo Pancreatic perfusion :  
The Perfusion 
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The pancreas was then removed and placed in a 50 mL tube. The excised 
pancreas was then digested at 37°C, without being cut into pieces or mechanically 
digested, for 15 min, being briefly shake by hand every 5 min. 
  
Once the incubation period was over the tube was shaken by hand for 15 
seconds to favour the disaggregation. Then, the tube was placed in ice with the purpose 
of terminating the digestion and 50 mL of RPMI complete medium were added. The 
solution was centrifuged for 5 min at 100g and 4ºC, and afterwards the pellet was 
resuspended in 25 mL of RPMI complete medium, filtrated to a new tube and the 
volume filled to 50 mL. The tube was then re-centrifuged for 5 min at 100g and 4º. The 
supernatant was discarded and the pellet was then resuspended in 10 mL of Histopaque 
1077, at that moment 10 mL of Hank’s were stratified very slowly in the falcon, using a 
syringe, this was followed by a centrifugation without acceleration and without brake at 
the speed of 900g and 20ºC. By the end of the centrifugation the ring of Islets was 
aspirated from interface between the Hank’s and the Histopaque, without the use of 
glass pipettes to avoid losing Islets due to attachment. 
Figure  12 Ex-Vivo Pancreatic perfusion : 
Isolating Pancreas 
Figure  11- - Ex-Vivo Pancreatic perfusion : 
Pancreas After Isolation 
 Chapter II – Material and Methods  
28 
 
 
After collecting the Islets, the volume was filled to 25 mL, centrifuged at 100g 
and 4 ºC for 5 minutes, and then the wash was repeated. Subsequently the supernatant 
was eliminated and the pellet was re-suspended in an adequate amount for plating. The 
islet yield and quality was checked on an inverted microscope. Culturing too many 
islets in the same dish causes the islets to become necrotic and degrade so, for the 
treatments 250-300 islets per 6cm dish with 2-3mls of media were used, in order to 
avoid stressing the islets.  
 
The advantages of perfusing the pancreas through the CBD are based on the 
allowance of the collagenase to access the islets using anatomical structures, and the 
reduction of mechanical damage to the islet through a stationary digestion.  
2.3 - Islet Disaggregation 
Dispersion of cells with Ca2+ -free medium was done immediately after the 
isolation of islets. All the islets were transferred into a tube containing 5 ml 0.25% 
trypsin-EDTA (Invitrogen, Paisley, UK). This was followed by a 5 minutes wait, and 
afterwards a centrifugation at 300g for 5 minutes. Four ml of supernatant were then 
removed and the islets dissociated by re-suspending the pellet very aggressively in the 1 
ml that remained. In order to remove the supernatant (because Ca2+ -free medium and 
trypsin are both toxic after a while for cells), the tubes were toped up to 10 ml with 
RPMI 1640 and centrifuged at 300g for 5 minutes to spin down the cells, then the 
supernatant was removed and the cells were re-suspended in RPMI and plated. 
Figure  13 -  Ex-Vivo 
Pancreatic perfusion : Ring of 
Islets after Gradient 
centrifugation 
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2.4 - Culture 
After performing islet isolation, proper culture conditions are imperative to 
ensuring that the islets are able to recover from the insult of collagenase digestion. An 
interesting notion is that there is no direct correlation between the β-cell apoptosis and 
glucose concentration. An increase in glucose concentration from 3 to 11 mM even 
promotes survival of β-cells. However, further elevation of glucose concentration 
increases β-cell apoptosis. Hence, RPMI 1640 medium with 11 mm glucose is optimal 
for culturing of pancreatic β-cells (Efanova, 1998; Carter el al, 2009). Overnight 
incubation of 16–20 hours provides islets time to recover from the harsh process of 
collagenase digestion. Recovery in a sterile incubator at 37°C with 5% CO2 infusion 
and humidified air is necessary for islet function prior to performing viability or 
functional assessment assays. To maintain islets for long-term culture, the optimal islet 
density is four islets per square centimeter in order to prevent competition for nutrients 
(Carter el al, 2009). Visual inspection of the islets can provide some rudimentary 
information regarding health. When viewed with a scanning objective lens under a light 
microscope, islets appear spherical and golden-brown, approximately 50–250 μm in 
diameter. These features, particularly the darker colour of islets in comparison to the 
relatively transparent exocrine tissue, allow a rapid identification of islets. 
Supplementing visual inspection with additional techniques can provide quantification 
of islet viability and functionality (Carter el al, 2009).  
2.5 - Hepatocyte In vivo Perfusion 
Primary hepatocytes provide scientists with a valuable tool for evaluating 
metabolic, biochemical, and molecular functions in a physiologically relevant, readily 
controlled in vitro experimental system. However, as is the case for all primary cells, 
there are unique considerations that must be taken into account to minimize batch-to-
batch variability and ensure the quality, reliability, and reproducibility of data (Zhang et 
al, 2010). Primary hepatocytes were obtained by collagenase perfusion of live mice. 
They were prepared for the perfusion through the exposition of the Portal-Vein, the 
initial procedure is similar to the described previously for the pancreatic perfusion, 
however there is a relevant difference, for the hepatic perfusion the mice were 
maintained alive and anesthetized. The liver was perfused through the Portal-Vein with 
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calcium and magnesium-free Hanks' buffered salt solution pre-warmed to 37 ºC for 4 
min at the rate of 4 mL/min, afterwards perfused with Sigma Type IV Collagenase 
(0,32mg/ml) at the same rate for 5 min. The digested liver was then gently, but as fast 
possible, excised and hepatocytes were released with gentle shaking of the digested 
liver into 15 ml of chilled (4 °C) William’s Complete Medium. The isolated material 
was then filtered through a 70-μm nylon filter, washed twice with the same medium by 
centrifugation at 50g for 3 and 5 min at 4 °C. After washing, the cells were resuspended 
in 10 hepatocyte isolation medium. In order to access the quality of the perfusion the 
cell viability was assessed via trypan blue staining and then the cells were plated. After 
allowing the cells to attach for approximately 2 hours at 37°C, they were washed once 
with PBS and the hepatocyte isolation medium was replaced with William’s 
Supplemented Medium. 
 
2.6 - Cell treatment 
The isolated and cultured β-islets, Hepatocytes and the MEF cells from different 
animals were treated with an environmental significant dose of Bisphenol A. In order to 
perform this treatment, Bisphenol A was used in 10
-9
 M dose for different times, in 
order to comprehend time/effects relationships.  
 
2.7 - Prime Design/ Test 
The primers were chosen according to literature or designed and their putative 
quality tested with the use of Primer3Plus. 
Primers Forward Reverse 
Bax ACAGATCATGAAGACAGGGG CAAAGTAGAAGAGGGCAACC 
SOD2 CGTGAACAATCTCAACGCCACCGA CCTCCAGCAACTCTCCTTTGGGTT 
Uqrcb GCGGGCCGATCTGCTGTTTC GCCTCATAGTCAGGTCCAGGGCT 
Gpx3 AAACAGGAGCCAGGCGAGAACT CCCGTTCACATCTCCTTTCTCAAA 
Ttc35 AGCAGGTCATGATTGCAGCCCT ACGCTTTCTGGCAGCAGTGTT 
VAPA GAGATGTGTGTTTGAAATGCCGA GGTCCGTCTTGTTTGGATGC 
Ndufs4 TGGCTACAGCTGCCGTTTCCG GGTCAGCGGTTGATGCCCAA 
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Zfand2A ACCCGTGAGTGCCAGGTGAT AACAGTGCTTCCCCAAGTCAGGA 
IARS GACTTGGAGGAGGTAGTGTGC GATGGGATGGTCAGGTGGTC 
Atp1b1 CTTCCGTCCTAATGACCCCA TGATTGATGTCGCCCCGTTC 
Atp6v1f ATCGAAGACACTTTCAGGCAA ATGCTCCTTGGACGGGATCT 
Gapdh ACCACAGTCCATGCCATCAC CACCACCCTGTTGCTGTAGCC 
Tub CAACACCTTCTTCAGTGAGACAGG TACATGATCTCCTTGCCAATGGT 
B2M CCGAACATACTGAACTGCTA TGCTATTTCTTTCTGCGTGC 
 
 
The PCR products were analyzed by agarose gel electrophoresis at 1% with 
incorporated ethidium bromide. The electrophoretic run occurred at 100 V, in an 
electrophoretic tank containing TAE (1X) and the gel was visualized with an UV 
transiluminator, using the software QuantityOne 4.6.1. 
2.8 - Cell Collecting 
To extract RNA from the cells in culture, the culture medium was removed and 
the plate was washed with 1X PBS. Afterwards the cells were incubated 5 min at 37ºC 
with trypsin 0.25% to assist the detachment from the plate. The cells were recovered to 
a microtube and the plate was washed 1X PBS to remove any remaining cells. The cells 
were then pelleted in a refrigerated microcentrifuge at 4ºC for 3 minutes at 12000 rpm.  
 
2.9 - RNA Extraction 
To perform the total RNA isolation, Trizol Reagent (Invitrogen) protocol was 
followed as company’s recommendations. 1 ml of Trizol Reagent was added to each 
tube, and the samples were allowed to completely dissociate by passing the mixture 
through a needle and by remaining for 5 min at 15 to 30ºC. Then, 0,2 mL of chloroform 
were added and the tubes were shaken by hand for 15 seconds, and incubated at 15 to 
30ºC for 3 minutes. The following step was a centrifugation at 12,000g for 15 min at 
4ºC.  The aqueous phase was recovered to a new tube and 500 μl isopropanol were 
added, mixed and kept at room temperature for 10 minutes, at that moment the samples 
were centrifuged at 12,000g at 4°C for 10 minutes. The pellet was washed with 1 ml 
70% ethanol, allowed to dry re-suspended in an adequate volume of H2O-DEPC. The 
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RNA concentration and purity was determined using the NanoDrop spectrophotometer, 
and then stored at -80°C for future use. 
2.10 - Phenol-Chloroform 
The RNA samples volume was filled to 400 µl with H2O-DEPC and a equivalent 
volume of phenol-chloroform acid was added. Then a 10 min a 4°C a 12000g centrifuge 
was made and the aqueous phase was recovered to a clean microtube. An 800 µl volume 
of isopropanol and 10 µg of glycogen were added. Subsequently the samples were 
incubated at -20ºC for at least 20 min and centrifuged at 16000 rpm for 30 minutes. 
Then the supernatant was removed and 500 µl of Ethanol 75% were added. A new 
centrifugation was made, at 7500 rpm for 5 minutes and the ethanol was removed, 
finally remained at RT for sensibly 7 min allowing it to dry and then re-suspended in 
and adequate volume of warm H2O-DEPC. The RNA concentration and purity was re-
determined using the NanoDrop spectrophotometer, as described previously. 
 
2.11 - Nanodrop 
The nucleic acids quantification was made with resorting to NanoDrop 
spectrophotometer ND-1000. The equipment was initialized and calibrated using 1 µl of 
H2O milliQ. The blank was made with DEPC H2O and then, the purity values (ratio 
between the absorbance at 260 nm and 280 nm and between the absorbance at 260 nm 
and 230 nm), and the concentration of nucleic acids was measured in ng/μl, depositing 1 
µl of each sample in the instrument. 
  
2.12 - Microarray 
The RNA was then prepared, purified, controlled and used for gene expression 
profiling analyses using the Affimetrix platform. The microarray was prepared in the 
GECO Laboratory from the Biogem Institute, and performed using a Mouse Afymetrix 
Gene Chip 2.0. 
The analysis of the data was performed using the GeneSpring Software. 
Ingenuity® Pathway Analysis (IPA) software was also accessed to obtain the 
information about gene prediction. 
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2.13 - Real Time PCR 
The Real Time experiment was conducted in Applied Biosystem 7300 Real-
Time PCR System, Power SYBR Green Master Mix was used (Applied Biosystems) 
and the analyses were done with SDS Enterprise Database software.  
 
2.14 - Cellular Viability 
In order to access the cell proliferation, cell viability, and cytotoxicity the MTT and the 
ATPLite assay were performed. Both assays were performed on cells treated with 
glucose at the concentration of 50 mM and BPA in the concentrations of 10-4, 10-6 and 
10-9. 
2.14.1 - MTT 
First an adequate number of cells were plated on a 96-well plate with the 
respective medium. Measurements were made at 24h, 48h and 7 days. On the measuring 
day, 10 µl of MTT reagent were added to each well. Incubation at 37ºC, inside the cell 
incubator, with the reagent was made for 2 hours. Afterwards the medium was removed 
and 100 µl of acidified isopropanol (0,04%) were placed on each well. The plate was 
then incubated at room temperature with agitation for 15 minutes. To conclude de assay 
absorbance at 570 nm was read in EnVision™ 2103 Multilabel Reader (Perkin Elmer). 
2.14.2 - ATPlite 
First an adequate number of cells were plated on Black 96-well plate with the 
respective medium. Measurements were made at 48h. On the measuring day, 50 µL of 
mammalian cell lysis solution were added to the each well, which already contained 100 
µL of medium. The microplate was then shaken for 5 minutes in an orbital shaker at 700 
rpm. Afterwards, 50 µL of substrate solution were added to the wells and the microplate 
was shaken for 5 minutes in an orbital shaker at 700 rpm. To finish the plate was dark 
adapted for 10 minutes and the luminescence was measured in Orion II microplate 
luminometer (Berthhold) using the Simplicity 4.2 software. 
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2.15 - TUNEL 
To access the apoptosis at the single cell level, the TUNEL assay was used. This 
technology is based on the detection of cleavages of genomic DNA that may result in 
double stranded low molecular weight DNA fragments, as well as single strand breaks 
in high molecular weight DNA. Those DNA breaks are identified through the labeling 
by terminal deoxynucleotidyl transferase, which catalysis polymerization of labeled 
nucleotides to the free 3’-OH DNA ends in a template-independent manner. The cells 
were plated in an 8-well slide chamber and treated for 48h with BPA at the 
concentration of 10-4, 10-6, 10-9, Glucose at 50 mM, and three controls (Negative 
Control; Positive Control; Experimental Control). After 48h the samples were fixed 
with freshly prepared Fixation Solution for 1h at 15 to 25ºC and once the incubation 
time was over the slides were rinsed with PBS. The cells were then fixated incubated in 
permeabilisation solution for 2 min on ice. Then the cells were incubated with the 
TUNEL reaction mixture. For the positive control the cells were DNase I for 10 min at 
15 to 25ºC, and for the negative control the cells were incubated with label solution 
without terminal transferase, instead of the TUNEL reaction mixture. Afterwards the 
cells were incubated for 60 min at 37ºC in a humidified atmosphere in the dark. When 
the incubation time ended the slides were washed with PBS and counterstained with 
DAPI, mounted with and observed under a fluorescence microscope. 
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3.1- Assessing the morphology of β-Islets 48 hours after the ex-vivo 
perfusion exposed to diferent doses of BPA 
To access the influence of BPA on β-Islets vitality and morphology, after the 
isolation and plating the β-Islets were treated with different doses of BPA, 10-4, 10-6 and 
10
-9 
mM and also a sample exposed to 50 mM of glucose, as positive control. When 
exposed to BPA there were no remarkable differences between in the number of viable 
Islets after the 48 hours, and the morphology of the Islet doesn’t appear to be 
influenced, Figure 6, In the same experimental settings, the reduction of the number of 
attached viable β-Islets was visible upon exposure to 50 mM glucose at (Figure 6 B). 
At higher magnification (Figure 7) we could see that a high glucose 
concentration inducted alterations in the structure of the Islet (the control a clearly-
defined regular border). Furthermore, the Islets exposed to BPA at 10-4 and 10-6 mM 
concentrations also had some changes in the morphology that became more irregular 
and with a granulated aspect . The exposition to BPA at 10-9 mM doesn’t appear to 
induce visible morphological changes. 
 
  A B C 
D E 
Figure  14- Morphology of β-Islets 48 hours after the ex-vivo perfusion. (A) Control; (B) 
Exposed to 50 mM Glucose ; (C) Exposed to 10
-4
 mM BPA; (D) Exposed to 10
-6
 mM BPA; (E) 
Exposed to 10
-9
 mM BPA 
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3.2 - Affimetrix Mouse Microarray 
 
As it was reviewed, in literature BPA exposure is associated with multiple 
diseases within multiple biological systems, so the chosen step was the realization of a 
microarray for three different tissues types, mouse embryonic fibroblast (MEF), 
Hepatocytes and β-Islets. DNA microarrays can simultaneously measure the expression 
level of thousands of genes within a particular mRNA sample. For the realization of this 
microarray, for each specific primary tissue the cells were obtained from 9 different 
animals and pooled 3 to 3. The microarray data were analyzed using the GeneSpring 
Software. The Figure 8A is constituted by a Volcano Plot of the data obtained. The 
Volcano plot allows the visualization of the relationship between fold-change and 
statistical significance (Tarca et al, 2006). There is a representation of the differential 
expression between the control condition and the 48 hours 10
-9
 BPA treated for 
hepatocytes (A), MEF (B) and β-Islets (C). A change of at least 1,5 fold (up or down) 
threshold was considered meaningful for the experiment, and as its observable the first 
two show no statistically significant differences in the expression between control and 
A B C 
D E 
Figure 15- Morphology of β-Islets 48 hours after the ex-vivo perfusion. (A) Control; (B) 
Exposed to 50 mM Glucose ; (C) Exposed to 10-4 mM BPA; (D) Exposed to 10-6 mM BPA; (E) 
Exposed to 10-9 mM BPA 
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treated samples. However, it’s visible in the Figure 8 C that for the treatment performed 
on β-Islets there is a small group of genes that have statistically significant expression 
differences between control and treated samples, that group of genes is assigned with 
the green color.  
In the Figure 9 it’s possible to see the heat maps made from the analysis of the 
microarray data from mouse embryonic fibroblast (MEF), Hepatocytes and β-Islets, the 
expression levels are represented by the pattern of colors, as is visible in the 
magnification done (Figure 9 D) in the we were able to see that for the treated β-Islets, 
there is a group genes represented by the green color have low expression levels when 
compared to the control samples.  
Surprisingly, the shown data indicated that BPA doesn’t have effects on cellular 
systems playing a role in diabetes other than the β-islet that, therefore, where used to 
further investigate the possible role of BPA on diabetes onset and progression. 
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3.2 A – Vulcano Plot 
 
  
Figure 16 - Vulcano Plot from the Microarray performed on 10-9 M BPA treated for 48 hours Hepatocytes (A), Mef (B) and 
β-Islets (C) 
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3.2 B - Heatmap  
 
  
Figure  17 - HeatMap from the microarray performed on 48 hours treated Hepatocytes (A), Mef (B) and β-Islets (C) with 10
-9
 mM BPA. In the right (D) 
there is a representative magnification of the genes that were found to be deregulated on β-Islets. 
A B C 
D 
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3.3 - Deregulated Genes 
The deregulated genes and their respective fold change is represented in the 
Table 1, as it was previously referred, a change of at least 1.5 fold (up or down), 
between treated and control, threshold was considered meaningful for the experiment. 
Given this threshold 22 genes were found to have at least 1.5 fold change. More 
precisely the fold change ranged from -1.5068305 and -2.301309 was found. 
Interestingly all of the 22 genes that had a statistically significant fold change were 
down-regulated comparing to the control condition.  
 
 
Table 1 - Deregulated genes obtained from the 10
-9
 BPA treated, 48 hours, β-Islets affymetrix 
microarray 
Symbol Entrez Gene Name Fold Change 
AFF2 AF4/FMR2 family, member 2 -1.6556648 
ATP1B1 ATPase, Na+/K+ transporting, 
beta 1 polypeptide 
-1.6410968 
ATP6V1F ATPase, H+ transporting, 
lysosomal 14kDa, V1 subunit 
F 
-1.5293903 
CRIPT cysteine-rich PDZ-binding 
protein 
-1.8414806 
GPX3 glutathione peroxidase 3 
(plasma) 
-2.0668383 
MAPK1IP1L mitogen-activated protein 
kinase 1 interacting protein 1-
like 
-1.6596464 
MAT2A methionine 
adenosyltransferase II, alpha 
-1.7497746 
POLR2F polymerase (RNA) II (DNA 
directed) polypeptide F 
-1.5068305 
RPL23 ribosomal protein L23 -1.843149 
RPP38 ribonuclease P/MRP 38kDa 
subunit 
-1.6528158 
Rps20 ribosomal protein S20 -1.618454 
TTC35 tetratricopeptide repeat 
domain 35 
-1.9058185 
ZFAND2A zinc finger, AN1-type domain 
2A 
-1.7261531 
ALG3 asparagine-linked 
glycosylation 3, alpha-1,3- 
mannosyltransferase homolog 
(S. cerevisiae) 
-1.8824571 
IARS isoleucyl-tRNA synthetase -1.5639364 
NDUFS4 NADH dehydrogenase 
(ubiquinone) Fe-S protein 4, 
18kDa (NADH-coenzyme Q 
reductase) 
-1.6941891 
PTPLB protein tyrosine phosphatase-
like (proline instead of 
-1.7596369 
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catalytic arginine), member b 
RPS11 ribosomal protein S11 -1.5685618 
SOD2 superoxide dismutase 2, 
mitochondrial 
-1.5526665 
TM2D1 TM2 domain containing 1 -1.5257024 
UQCRB ubiquinol-cytochrome c 
reductase binding protein 
-2.301309 
VAPA VAMP (vesicle-associated 
membrane protein)-
associated protein A, 33kDa 
-1.5426713 
 
3.4 - Transcription Factors 
In order to proceed with the analysis of importance of the genes that were found 
deregulated, the data obtained was processed and analyzed with the IPA Software. 
Firstly, the determination of the transcription regulators (TF) involved in the altered 
gene expression of the reported gene was done and they are listed in Table 2. The p-
value and the respective targeted genes that were part of our initial deregulated genes 
list are also reported.  
 
Table 2 - Transcription Factors associated with the deregulated genes (referred in the right 
column)  
Transcription Regulator p-value of overlap Target molecules in dataset 
HTT 4.87E-03 GPX3,NDUFS4,SOD2,UQCRB,VAPA 
NR3C2 (includes 
EG:110784) 
7.21E-03 ATP1B1,GPX3 
KLF11 9.09E-03 SOD2 
FOXO3 1.82E-02 IARS,SOD2 
MXI1 2.53E-02 IARS 
TFAP2B 2.53E-02 SOD2 
SP2 2.71E-02 MAT2A 
MYC 3.15E-02 MAT2A,RPL23,Rps20,SOD2 
MED30 3.24E-02 SOD2 
HOXA13 3.42E-02 VAPA 
SP4 3.42E-02 MAT2A 
Ikb 3.94E-02 MAT2A 
Stat3-Stat3 3.94E-02 SOD2 
NPM1 4.12E-02 SOD2 
DDIT3 4.82E-02 SOD2 
 
3.5 - Canonical Pathways 
 
Additionally, to identify if the deregulated genes were involved in any 
fundamentally and biologically specific disorders, we performed IPA Canonical 
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Pathway analysis using the list of differentially expressed genes which resulted in the 
determination of two statically significant Canonical pathways, mitochondrial 
dysfunction and oxidative phosphorylation as it’s visible in the Figure 12. 
 
 
Figure 18 - IPA Analysis Canonical Pathways Prediction 
 
 
3.6– Networks 
In order to gain further insight into the mechanisms responsible for this gene 
expression alteration, ingenuity pathway analysis (IPA) was performed, which 
determined whether the predicted targets formed a network of interactions. The analyses 
resulted in a list of 4 network eligible genes. To construct the network, we included 
additional nodes which were not predicted as targets by the microarray. In Table 3 the 
list of genes included in the 4 different networks is available, where the array predicted 
genes are assigned with a *, the IPA also predicts a score for the predicted networks, as 
such in the Figure 19 and 20 there are represented the most significant networks 
identified by Ingenuity pathway analysis (IPA), with the green molecules representing 
downregulated genes. Ellipse, square, triangle, trapezoid, lozenge and circle represent 
transcription regulator, cytokine, kinase, transporter, enzyme and other molecules, 
2,12 2,12 
0,00 
0,50 
1,00 
1,50 
2,00 
2,50 
 -log(B-H p-value)  
IPA Analysis Canonical Pathways 
Mitochondrial Dysfunction Oxidative Phosphorylation 
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respectively. Arrows connecting molecules indicate one molecule acts on another and 
lines indicate one molecule binds to another. 
Table 3 - Putative Molecule Networks List derived from IPA Analysis and the respective 
calculated score and Top Functions 
Network Molecules in Network Score Focus Top Functions 
1 ACTR3, AFF2*, ATP1B1*, ATP6V1F*, BAZ1A,BCCIP, 
CRIP2, CRIPT*, EIF4E, EPCAM, FAM158A, FXYD1, 
GPX3*, GRB2, HNF4A, KRAS,MAPK1IP1L*, MAT2A, 
MYC, PAF1, POLR2F*, POLR2K,POLR3D, POP7, 
RPL23*, RPP30, RPP38*, Rps20*, SEPHS1, SP2, 
tretinoin, TTC35*, UBE21, ZFAND2A* 
33 13 Cell Cycle, 
reproductive 
System 
Development 
and Functions, 
Cancer 
2 ALG3*, APP, CYTB, DARS, DUSP10, IARS*, IL4, INPP1, 
KL,MAP3K7, mir-23, ND2, ND3, ND4,ND5, 
ND6,NDUFS4*, NDUFS6, nitrate, NOXO1, PSME1, 
PTPLB*, RPS11*, RPS18, SLC19A2, SOD2*, TM2D1*, 
TMEM131, TNF, UQCRB*, UQCRC1, UQCRHL, 
UQCRQ, VAPA*, VEGFA 
20 9 Free Radical 
Scavenging, 
cellular 
Development, 
Hematological 
System 
Development 
and Function 
3 TM9SF3*, UNC93B1 3 1 Infectious 
Disease, 
Genetic 
Disorder, 
Inflammatory 
Disease 
4 STAT4, TMEM167B* 3 1 Cell Cycle, Cell 
Death, 
Hematological 
System 
Development 
and Function 
 
  
Figure  19 -Putative Molecule Network 1 derived from IPA Analysis - symbols in the 
figure represent the following: Solid line: Direct interaction. Dashed line. Indirect 
interaction. 
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3.7 Real Time Gene Validation 
 
Microarray results can be influenced by each step of the complex assay, from 
array manufacturing to sample preparation (extraction, labeling and hybridization) and 
image analysis so a validation of expression differences accomplished by an alternate 
method is required. Real time PCR was the strategy chosen to perform this validation 
since it is rapid and quantitative method and applicable to samples with limited amount 
of RNA (Rajeevan, 2001). The Real-Time PCR validation was done normalizing the 
results with B2M and Tubulin using the Delta Delta Ct Method. In the Figure 13 are 
presented the real time results obtained using β-Islets, we analyzed the gene expression 
from 11 of the 22 genes that we found down regulated on the microarray. Four different 
time-points of treatment were analyzed, 12 hours, 24 hours, 48 hours and 7 days. As it’s 
observable with exception made to the gene Ttc35 all of the genes appeared inhibited 
when treated with BPA at the concentration of 10
-9
 mM at 48 hours, the time point used 
Figure  20 - Putative Molecule Network 2 derived from IPA Analysis 
symbols in the figure represent the following: Solid line: Direct 
interaction. Dashed line. Indirect interaction. 
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in the microarray. Furthermore there was a general tendency of down regulation for all 
of the genes in every time point.  
Additionally to ensure that the deregulated gene expression had a specific 
character for β-Islets, we decided to validate the gene expression of those genes on Mef 
(Figure 14) and on Hepatocytes (Figure 15), for same four time points used in the 
validation performed for the β-Islets. As it’s observable, in contrast with the treated β-
Islets, with the with exception made to Gpx3 on the Mef cell line, that exhibited a 
strong variation, all of the genes chosen for the validation were very stable and their 
expression doesn’t appear influenced by BPA at the concentration of 10-9 mM. 
The Table 4 constitutes a comparative resume of the fold change found in all 
3 cell types after 48 hours of treatment with BPA at 10-9 mM. 
 
 
Figure 21 - Real-Time Validation for β-Islet treated with BPA 10
-9
 for 12 hours, 24 hours, 48 hours and 7 days. Data 
represents mean+SEM of at least 3 independent experiments. * p<0.05; **p<0.01; 
***p<0.001. (versus control) Condition (Two way ANOVA followed by Bouferroni Post hoc test) 
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Figure 22 - Real-Time Validation for Mef treated with BPA 10
-9
 for 12 hours, 24 hours, 
48 hours and 7 days. Data represents mean+SEM of at least 2 independent experiments. 
(versus control)  Condition (Two way ANOVA followed by Bouferroni Post hoc test) 
  
 
 
Figure 23 - Real-Time Validation for Hepatocytes treated with BPA 10
-9
 for 12 hours, 24 hours, 
48 hours and 7 day.  Data represents mean+SEM of at least 3 independent experiments. (versus 
control) Condition (Two way ANOVA followed by Bouferroni Post hoc test) 
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12h            24h       48h                168h 
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Table 4 - Gene Fold Change obtained from Real-Time PCR analysis performed on β-Islets, Hepatocytes and Mef 
treated with 10-9 mM BPA for 48 hours. 
Cell Type Islets Mef Hepatocytes 
Gpx3 0,55 0,48  
Sod2 0,75 1,18 0,93 
Uqrcb 0,8 - 0,86 
Zfand2a 0,79 0,86 - 
Ndufs4 0,67 1,03 0,87 
Atp1b1 0,77 1,01 0,96 
Atp6v1f 0,58 - 0,89 
Alg3 0,61 - - 
Iars 0,59 - - 
Vapa 0,67 1,14  
Ttc35 1,7 - - 
 
 
3.8 Citotoxic Activity 
The canonical pathways found through the Ingenuity® Pathway Analysis  
analysis associated the exposition to BPA with mitochondrial dysfunction and oxidative 
phosphorylation. Consequently we have verified if the BPA exposition resulted in an 
alteration of cell mortality as well as in ATP  
3.8.1 – MTT 
 
The MTT assay was used to investigate the cytotoxic effect of BPA at diverse 
concentrations. The treatment of performed on disperses β-Islets and lasted 48 hours. As 
it’s visible in the Figure 16 BPA exerts cytotoxic activity on dispersed β-Islets in a dose 
dependent manner, with the concentration of 10-4 mM having the stronger effect (0,63), 
10-6 mM an intermediate effect (0,67) and the 10-9 mM resulting in the lower effect 
(0,77). As a positive control we used a concentration of 50 mM of glucose in which we 
found that the viability decreased 50% (0,5).  
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Figure  24 - MTT Assay - The data comes from a n=3 , with the 3 doses of BPA and the 50 mM of Glucose being 
confronted with the control 
 
3.8.2 – Atplite 
To have a direct measure of the ATP production, ATP intracellular level was 
determined by the ATPLite
TM 
(PerkinElmer). The results showed a dose dependent 
reduction of ATP production that was 0,77 at 10-9M when compared with control. 
Results obtained with this technique were in agreement with the results obtained 
previously with the MTT, with BPA exerting cytotoxic activity in a dose dependent 
manner, as it’s visible in the Figure 17. 
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Figure  25 - ATPlite Assay - The data comes from a n=2 , with the 3 doses of BPA and the 50 mM of Glucose being 
confronted with the control 
  
3.9 – TUNEL Assay 
 
As previously referred results obtained from the Cellular metabolic activity 
assays indicated that the exposition to BPA is able to affect the viability of the Cells. In 
this sense we decided to assess the apoptosis at the single cell level and for that we 
performed TUNEL assay, by IF, on dispersed Islets. For the realization of the TUNEL 
assay apart from the 10-9 mM of BPA exposition, that was the concentration of main 
interest for us, BPA at 10-4, 10-6 and Glucose at 25mM were also tested. This choice 
was necessary due to the restricted surviving time of beta islets in culture, together with 
the absence of information about the necessary time to make it morphologically 
detectable. The cells were stained with DAPI, to evidence the nuclei (Figures 16 A to 21 
A), with the TUNEL reagent (16 B to 21 B) and in Figures 16 C to 21 C the merge from 
the previous, two for each treatment, were shown. In the Figure 16 it’s observable that 
in the untreated samples there is no strong staining from TUNEL, only a weak 
background which indicates the absence of apoptosis. For the Figures representing the 
exposition to BPA 10-4, 10-6 mM (Figures 17 and 18 respectively) a considerable signal 
of apoptosis is visible, with ¼ of the cells displaying a strong apoptotic signal. In the 
Figure 19 we could observe that apoptosis was also present, however to a less extent 
then the higher concentrations. The 25 mM Glucose treatment yielded a result that was 
0,00 
0,20 
0,40 
0,60 
0,80 
1,00 
1,20 
C 10-4 10-6 10-9  50mM 
Série1 
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B A C 
very similar to the exposition to BPA 10-4/10-6 as it’s visible in the Figure 20. The 
figure 21 constituted the positive control in which the cells were treated with DNase 
2000U before the staining, and where we can see 100% positive apoptotic cells.  
 
 
 
 
 
 
  
 
B A C 
Figure  26 - Dispersed β-Islets non-treated (control) for 48 hours stained with DAPI (A); TUNEL 
Reagent (B) and Merged stains (C) 
B A C 
Figure  28 - Dispersed β-Islets treated with 10-4 BPA for 48 hours stained with DAPI (A); TUNEL 
Reagent (B) and Merged stains (C) 
Figure  27 - Dispersed β-Islets treated with 10-6BPA for 48 hours stained with DAPI (A); TUNEL 
Reagent (B) and Merged stains (C) 
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B A C 
 
B A C 
B A C 
 
 
  
Figure  29 - Dispersed β-Islets treated with 10-9 BPA for 48 hours stained with DAPI (A); TUNEL 
Reagent (B) and Merged stains (C) Figure  30 - Dispersed β-Islets treated with 25m of Glucose for 48 hours stained with DAPI (A); 
TUNEL Reagent (B) and Merged stains (C) 
Figure  31 - Dispersed β-Islets treated with DNase 2000U (Positive Control) for 48 hours stained 
with DAPI (A); TUNEL Reagent (B) and Merged stains (C) 
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3.10 – Real Time Analysis – Bax 
 
After the TUNEL assay performed on dispersed β-Islets, and the evidence that 
BPA at the concentration of 10-9 mM can induce apoptosis in this cells, the analysis of 
the expression of pro-apoptotic genes during the treatment with BPA was the chosen 
approach to understand to which extent the BPA influences the Islets of Langerhans. 
Apoptosis is a genetically controlled cell suicide pathway which plays an essential role 
in deleting excess, unwanted or damaged cells during development and tissue 
homeostasis and Bax is a pro-apoptotic protein that induces cell death through 
homodimerization and heterodimerization with bcl-2 and other members of the bcl-2 
protein family. Consequently, we opted to determine the expression of Bax within 
different time points of treatment with BPA. We evaluated the expression of the gene 
Bax in β-Islets treated with BPA at 10-9 nM at 12 hours, 24 hours, 48 hours and 7 days 
is represented. The data is normalized for B2M and Tubulin given the Delta Delta Ct 
Method. In the Figure 22 it’s observable that Bax is upregulated when compared to 
control in all of the time points that were controlled. Moreover at 48 hours was a 2,27 
fold expression was reached, in agreement with the results obtained from the TUNEL 
assay. 
  
0,10 1,00 
12h 
Bax 
Figure  32 -Real-Time analysis of Bax expression for β-Islets treated with BPA 10-9 for 12 hours, 24 
hours, 48 hours and 7 days. Data represents mean+SEM of at least 3 independent experiments * p<0,05  
Condition (one way ANOVA) 
BAX 
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3.11 – Pathway Inhibitors 
To get some details about the apoptosis pathway that we found, and taking in 
account the deregulated genes and respective transcription factors we decided to 
perform a treatment with four possible compounds capable of inhibiting diverse 
pathways through which the BPA may act and exert the cytotoxic effects that were 
found. The chosen compounds were the antioxidant - N-Acetyl-l-cysteine (Nac), the 
IkappaB kinase (IKK) inhibitor – BMS 345541, the inhibitor of the MAPK - LY and the 
conventional Estrogen Receptor inhibitor - ICI. After 48 hours of treatment an analysis 
of the expression of BAX was made through Real-Time PCR and, as it’s visible in the 
Figure 23, only BMS 345541 appeared to inhibit the expression of the gene BAX.  
 
  
Figure 33 - Real-Time analysis of the expression of Bax in β-Islets treated with BPA 10
-9
 for 48 hours and 
simultaneously BMS (A); Nac (B); ICI (C)  
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Exposure to low levels of EDCs may be of concern. This is seemingly 
ubiquitous in today's environment, and EDCs are detectable in nearly all human blood 
samples, and even some of the shorter-lived potential endocrine disruptors are 
frequently detected in general population surveys as residues in blood or urine. The near 
omnipresence of the exposures combined with the nontrivial potential health effects 
justifies further research; the sensitivity of the human epigenome to low levels of EDCs 
will directly influence the health of current and future populations (Elobeid and Allison, 
2008; Bernal and Jirtle, 2010). BPA is a polycarbonate used in numerous consumer 
products, including food and water containers, lining of food and beverage metal cans 
and medical tubing, becoming an important contaminant due to its ubiquitous presence 
and the increased exposure (Ben-Jonathan et al, 2009; Lam et al, 2011). 
BPA exposure is associated with multiple diseases, such as reproductive system, 
nervous system and sexual dysfunctions as well as increased risk of cancer and heart 
disease (Gong et al, 2013). Studies in rodents have demonstrated that exposure to BPA 
elicits alterations in glucose homeostasis and correlation between BPA and the 
occurrence of diabetes has been found (Batista et al, 2012; Gong et al, 2013). Given its 
prevalence in the environment, presence in serum from humans worldwide, suppression 
of adiponectin and increased IL-6 and TNFα release, BPA may be, bona fide, the 
endocrine disruptor that adversely affects metabolic homeostasis (Ben-Jonathan, 2009).  
Therefore, the endocrine disruption by BPA represents a real risk factor and, 
since the studies conducted so far resulted in conflicting data, future studies are required 
in order to determine the role of this compound in the development of multiple 
disorders namely, obesity, diabetes, and other related to metabolic disorders.  
Thus, in this work we purposed to dissect the mechanisms of the endocrine 
disruptor Bisphenol A, in the regulation of the transcripts in 3 cellular settings related to 
diabetes onset and glucose production: Pancreatic Islets of Langerhans, mouse 
embryonic fibroblast (MEF) and hepatocytes. With Diabetes Mellitus (DM)  being 
classified into four main groups, Type 1 DM results from lack of insulin production due 
to selective autoimmune destruction of pancreatic β-cells; Type 2 DM which is caused 
by insulin resistance in the main target tissues (liver, muscle, and fat), is also associated 
with alterations in hepatic metabolism, that leads to overproduction of glucose and 
lipids, which in turn is associated with the development of glucose intolerance and 
dyslipidaemias and indubitably inadequate compensatory insulin secretion response by 
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β-cells; other specific type of diabetes that include genetic defects of the β-cell; and 
gestational diabetes mellitus (GDM), characterized by glucose intolerance with onset or 
first recognition during pregnancy (Mellado-Gil et al, 2012; Sajan and Farese, 2012). 
Methodologically, we chose a Systems Biology approach that presented some 
operative problem as the amount of protein required for a classical proteomic approach 
(2D-GEL and MS/MS analyses) is very high and requiring the sacrifice of a large 
number of mice. Therefore, we decide to explore firstly and definitely the role of BPA 
by transcriptomic approach, validate the data also functionally in order to properly use 
the animals. Furthermore, we obtained the Danio Rerio transgenic line (INS- GFP, 
control strain and reference by P. Argenton). The INS-GFP strain allows the 
handpicking of the β-Islets, so the Danio Rerio are going to be subjected to an in-vivo 
treatment with an environmental relevant dose of  BPA, and subsequently the β-Islets 
are going to be picked and the analysis done  for the mouse β-Islets (treated in-vitro) are 
going to be executed. The Danio Rerio transgenic line arrived one month ago and it will 
be ready for the experiments in the next months.  
To begin with, as it’s visible in Figure 14 and 15 the influence of BPA in the 
morphology of the β-Islets, after 48 hours of treatment, was inspected. We couldn’t 
observe relevant diameter alterations, but on the other hand from the three chosen 
concentrations we were able to observe that both 10-4 and 10-6 mM BPA treatments 
appear to induce some changes in the morphology of the Islet, with the border becoming 
less defined and with the whole Islet gaining a granulated aspect. The treatment with 50 
mM glucose induced stronger but similar morphological changes and the exposition to 
BPA at 10-9 mM doesn’t appear to induce visible morphological changes.  
To investigate possible mechanisms leading to defects in the function of the β-
Islets we decided to use a toxicogenomical approach, that is based on the application of 
global mRNA, protein and metabolites analysis related-technologies to study the effects 
of hazards on organisms (Vulpe and North 2010), for that reason after the treatment 
with BPA at 10-9 mM for 48 hours of 9 β-Islets samples, 9 primary hepatocyte samples 
and nine MEF samples obtained from 9 different animals for each cellular type (with the 
respective control samples aswell) three microarray experiments were performed. 
 In contrast to DNA itself, the transcription of DNA to RNA is very labile and 
specific to tissues and to cells within tissues because gene expression is responsive to 
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the cellular and extra-cellular environment. RNA microarrays make it possible to take 
snapshots of profiles of gene expression throughout the genome for different groups and 
in different tissues (Plomin and Schalkwyk, 2007). In this work an evaluation of the 
effect of BPA on the gene expression profile, control versus treated at 10-9 mM was 
performed in the three different mentioned primary cell cultures. The analysis of the 
data obtained from the array experiments was performed with the GeneSpring software 
and with a change of at least 1.5 fold (up or down) threshold being considered 
meaningful for the experiment the result pointed out to a tissue specific effect. After the 
analysis we could observe that it wasn’t detected any statistically significant variation of 
gene expression in the MEF and hepatocyte treatment. However, the microarray 
performed on the treated β-Islets retrieved a short list of genes that yielded statistically 
significant variation of gene expression for a group of 22 genes, represented on table 1.  
Qin et al, 2013 reported that short-term exposure of BPA at environmentally 
relevant concentrations disturbs the upper hierarchies of hypothalamus-pituitary-
gonadal axis at the transcription level, Dairkee et al, showed that BPA exposure induces 
aberrant expression of multiple checkpoints that regulate cell survival, proliferation and 
apoptosis and Saili et al, 2013 concluded that following a 0.1 µM BPA exposure a 
suppression of the expression of several genes involved in nervous system development 
and function occurred. However we couldn’t find previous works evaluating gene 
expression influence by BPA at environmental relevant concentrations on β-Islets.  
The IPA Software was used in the determination of the canonical pathways, 
allowing the identification of the involvement of the deregulated genes in any specific 
disorder. The analysis resulted in the determination of two statically significant 
Canonical pathways, mitochondrial dysfunction and oxidative phosphorylation as it’s 
visible in the Figure 18. Moon et al, 2012 observed that a 10 nM and 100 nM dose of 
BPA induced mitochondrial dysfunction in the liver, on the other hand we found that 
1nM BPA dose doesn’t cause significant gene deregulation in primary hepatocyte 
cultures, yet as referred the predicted canonical pathway on β-Islets also pointed out to 
mitochondrial dysfunction. To obtain the maxim information possible about the data 
obtained from the IPA Software was also used to predict putative networks of 
interaction for the deregulated genes, the data presented in table 3 is referent to the 4 
predicted networks, and the two networks that obtained the highest score are shown in 
the Figure 19 and Figure 20.   
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As previously said, within the list of genes that were influenced by BPA we 
found ATP6v1F to be down regulated. This gene encodes a component of vacuolar 
ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic 
intracellular organelles. NDUFS4 or NADH ubiquinone oxidoreductase expression was 
also deregulated, it constitutes the first multisubunit enzyme complex of the 
mitochondrial respiratory chain and plays a vital role in cellular ATP production.   
Olsson et al, 2011 examined the association between if there was a differential 
expression from genes involved in the Oxidative Phosphorylation in human β-Islets of 
patients with Type II Diabetes, and concluded that there was a decreased expression of 
genes like ATP6V1H, ATP6V1E2, ATP6V1C1 NDUFA10, NDUFA5, NDUFS1, 
NDUFS5, among others. Despite not finding genes with decreased expression in 
common with our work, there are genes closely related and this fact goes in agreement 
with the association between Diabetes and the exposition to BPA that is documented in 
literature. We also found the superoxide dismutase 2 transcript. This gene codifies the 
enzyme SOD2 and its main function is to convert superoxide anion into hydrogen 
peroxide, which is subsequently converted to water by catalases leading to the reduction 
of reactive oxygen species levels. Reduced expression levels of SOD2 have been shown 
to result in increased mitochondria DNA damage l (Hurt et al, 2007). Although we 
couldn’t find information about the influence of BPA on the SOD2 activity, Kabuto et al 
2003, within a study in vivo observed that the SOD activity increased in liver and on 
brain, lung, kidney, and fat body didn’t change significantly when male ICR mice were 
exposed to BPA with in a 5 days treatment through intraperitoneally administered doses 
of both 25 and 50 mg/kg/day. Still, neither the pancreatic tissue nor the evaluation of the 
mitochondrial form of SOD expression in the other tissues was made.  
Mitochondrial dysfunction is associated with β-cell function, ultimately leads to 
apoptosis and contributes to the development of diabetes (Supale et al, 2012). It has 
been well documented that BPA can trigger apoptosis in various cells and tissues 
through mitochondrial signaling pathways (Lyn et al, 2013). Song et al, 2012 also 
observed that BPA significantly attenuated rat isolated Islets viability with a of 10 nM 
dose for 24 hours. Lyn et al, 2013, using a rat insulinoma cell (INS-1) line observed that 
after 24 and 48 hours of exposition BPA at 2 nM decreased cell viability and increased 
apoptosis in a dose-dependent manner. The utilization of a mouse insulinoma β-TC6 
cell line was also a part of our approach at start, however the analysis of the influence of 
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BPA at 1 nM retrieved results that weren’t similar to the ones obtained for the primary 
β-Islets, since there was neither a significant deregulation of the expression of the set of 
genes nor a decrease in the cell viability (data not shown). This fact pointed out the need 
of continuing with the use of primary cells. 
Due to this direct relationship we decided to verify if BPA exposition elicited 
any alterations on cell viability. Two distinct techniques were used to evaluate the 
influence of BPA in the cellular viability, the MTT and the ATPlite. Despite not being 
numerically the same, with the 1 nM presenting a 0.77 viability for the MTT assay and 
0,89 for the ATPlite assay, the results obtained from the both assays were concordant 
and reflected that BPA had a dose dependent cytotoxicity. Moreover, ATPlite assay is a 
direct measure of the ATP production that, as expected, was reduced. The difference 
among the two assays suggested it would be interesting to further determine the ATP 
production at shorter time exposure, which is now under evaluation.  
In this sense we decided to assess the apoptosis at the single cell level, through a 
realization of the TUNEL assay using treated (BPA at 10-4, 10-6, 10-9 and Glucose at 
25mM) and observation by Immunofluorescence. The various doses of treatment were 
used because there is not much information regarding the time of exposition to BPA 
needed to obtain a morphological detection of apoptosis. We used a 48 hours exposition 
to BPA and the results obtained confirmed the previously described cell viability assays, 
with BPA exhibiting a dose dependent role in the apoptosis of the dispersed β-Islets, as 
it’s visible in the figures 27 to 29.  The higher dose of BPA 100 μM had an effect that 
was similar to the 25 mM glucose exposition and showed the highest cytotoxicity, the 1 
μM treatment dose reflected an intermediate phenotype and the 1 nM dose displayed a 
minor but present, apoptosis signal.  
In healthy cells, BAX (inactive) is located in the cytosol or is loosely attached to 
membranes, but in response to stress signals, BAX enters into the mitochondria and 
induces cell death through homodimerization and heterodimerization with bcl-2 and 
other members of the bcl-2 protein family, resulting in downstream mitochondrial 
dysfunction. It is reported to interact with, and increase the opening of, the 
mitochondrial voltage-dependent anion channel (VDAC), which leads to the loss in 
membrane potential and the release of cytochrome C (Ruiz-Vela et al, 2005). Therefore, 
we determined the expression of Bax within different time points of treatment with BPA 
at 10-9 nM at 12 hours, 24 hours, 48 hours and 7 days. As expected from the previous 
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results, the expression of Bax was increased in all the time points tested when compared 
to control. In agreement with the MTT/ATPlite and the TUNEL assay, at 48 hours Bax 
reached 2.37 fold expression and so, evidencing the pathway through which the 
apoptosis occurred became mandatory. To do so, a treatment with compounds capable 
of inhibiting apoptotic was done. The treatment with the inhibitors started 1 hour before 
the BPA treatment, and the chosen compounds were the Nac, BMS 345541 and ICI. 
The antiestrogen ICI 182, 780 was used to observe if these effects were mediated 
through classic estrogenic pathway. N-acetyl-L-cysteine (NAC) was used due to his role 
as identifier and tester for ROS inducers, and the capacity of inhibiting ROS (Halasi et 
al, 2013). BMS 345541 down-regulates the IKK activity, which contributes to the 
degradation of substrate IκB proteins. The IκB is responsible for retain the transcription 
factor NF-κB in the cytoplasm, avoiding its entrance in the nucleus and subsequent 
transcription. Papaccio et al, 2005 observed that in β-Cells the activation of NF-κB, 
regulates MnSOD gene expression to protect β-islet from cytokine damage. However, 
the progression of β-cell deterioration leads to an induction of apoptosis through NF-κB. 
The analysis of the expression of BAX was made through Real-Time PCR and, as it’s 
visible in the Figure 35 and only BMS 345541 inhibited the expression of the gene 
BAX, evidencing a possible pathway for the action of BPA on β-Islets. This result is 
preliminary and based on a single experiment, due to limited time; therefore its 
reproducibility must be evaluated. Nonetheless, it is an encouraging result.  
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This work is foremost a contribution to clarify the role of the endocrine 
disruption by BPA in the activity of β-Cells. BPA is a compound with ubiquitous 
presence of in the environment and above all with possibility of leaching that it presents 
it becomes a risk factor for various disorders in multiple axes.  
The demonstration that a 1nM dose that is environmentally relevant (since 
higher concentrations have been reported in human urine and blood) is able to disrupt 
the β-cell function allows us to conclude that the preliminarily discerned pathway goes 
in concordance with the association between the development of Diabetes and the 
exposition BPA present in literature, since BPA showed a role in the promotion of 
apoptosis in mouse β-Islets.  
Moreover from the three primary cultures analyzed we found this action as 
specific to β-Islets, therefore understanding how’s possible to reduce this effect on β-
Islets may be the following step.  
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